The Food and Drug Administration warned Kim Kardashian for violating the federal drug promotion rules after promoting a drug named Diclegis on her social media account. The Keeping Up With The Kardashians star personally promoted and recommended the drug for women suffering from morning sickness on her Instagram.
The fashion icon, who is now pregnant with her second child with Kanye West, took advantage of her condition to promote the drug for morning sicknesses on her account.
"I tried changing things about my lifestyle, like my diet, but nothing helped, so I talked to my doctor. He prescribed me #Diclegis, and I felt a lot better and most importantly, it's been studied and there was no increased risk to the baby."
FDA regulators claim that the posts violate rules for drugs promotion because the reality star failed to mention the possible side effects of the medicine. Kim Kardashian only enumerated the positive effects of Diclegis without including the side effects which include sleepiness that hinders consumers to perform activities requiring mental alertness.
Diclegis should not be taken along with alcohol and other medications that can cause drowsiness like pain relievers. Kim did not also included in the posts that women who are experiencing prolonged vomiting are not approved to take the drug due to risk of dehydration.
The famous personality has more than 25 million followers on Facebook and 42 million on Instagram. With the posts, the star could have endangered the lives of many women.
The FDA already posted an online warning letter to the CEO of Duchesnay, the Canadian drug maker that manufactures Diclegis. The agency ordered the company to remove the social media posts.
In 2013, the drug maker has also received the same warning after omitting important risk information from the doctors. The company stated that it will be taking necessary actions immediately to address the issue.
The FDA requires all pharmaceutical companies and drug makers to balance the benefits and the side effects on the label and when promoting their products to avoid health risks even when space is limited.
